Archived Cancer Center Grand Rounds
Mcl-1 and the Bcl-2 Family Death Control for the Life of the Whole
May 7, 2013
Speaker:
Ruth W. Craig, Ph.D., Department of Pharmacology and Toxicology
Dysregulated signaling in sarcoma: Biomarkers & novel therapies
April 30, 2013
Speaker:
Jonathan A. Fletcher, MD, Harvard Medical School
EWS/FLI and its targets in Ewing Sarcoma
April 16, 2013
Speaker:
Stephen L. Lessnick, MD, PhD Huntsman Cancer Institute Adjunct Assistant Professor, Oncological Sciences
A Fresh Look at Advance Directives & Advance Care Planning - From Chore to Key Quality Improvement Strategy
April 2, 2013
Speaker:
Ira Byock, MD and Claire Pace, MSN, APRN
RAPPORT - Electronic Proposal Routing and Submission
March 26, 2013
Speaker:
Stephanie Morgan, RAPPORT Subject Matter Expert, Dartmouth College, and Heather Arnold, Assistant Director, Office of Sponsored Projects
Targeted Cancer Therapeutics: Response and Resistance
March 12, 2013
Speaker:
Jeffrey A. Engelman, MD, PhD Harvard Medical School
Stereotactic Radiosurgery Following Resection of a Brain Metastasis: DHMC's Past Experience and Novel Directions
March 5, 2013
Speaker:
Alan C. Hartford, MD, Ph.D.
Matrix Metalloproteinase-1; A tale of a frog that became a prince.
February 26, 2013
Speaker:
Constance Brinkerhoff, PhD, Nathan Smith Professor of Medicine and of Biochemistry, Associate Dean for Science Education
Using the State Cancer Registry for Population-based Cancer Research
February 12, 2013
Speaker:
Thomas Tucker, MPH, PhD College of Public Health, University of Kentucky
Systems Dynamic of Estrogen Receptor Biology
February 5, 2013
Speaker:
Edison Liu, M.D., President and Chief Executive Officer, The Jackson Lab
Eliminating Exposure to Secondhand Smoke: Helping smokers protect their loved ones from a prevalent cancer risk
January 15, 2013
Speaker:
Susanne Tanski, MD
Translating Science into Social and Political Change C. Everett Koop Distinguished Lecture
December 13, 2012
Speaker:
Stanton A. Glantz, PhD University of California, San Francisco
Collateral Damage: Causes and Consequences of Genomic Instability
December 6, 2012
Speaker:
Kevin D. Mills, PhD The Jackson Laboratory
Blessing and Battles Understanding Decisions and Actions in Care of Older Oncology Patients Marilyn K. Bedell Distinguished Lecture in Oncology Nursing
November 29, 2012
Speaker:
Sarah H. Kagan PhD, RN University of Pennsylvania
Know Your Chances: Making Sense of Cancer Risk
November 9, 2012
Speaker:
Steven Woloshin, MD, MS and Lisa M. Schwartz, MD, MS
Liberating the Immune System to Cure Human Cancers Targeting of Negative Checkpoint Regulators
November 9, 2012
Speaker:
Randolph J. Noelle, PhD
Finding Signals in the Noise Phosphoproteomics to Study Cancer Cell Signaling
November 9, 2012
Speaker:
Scott A. Gerber, PhD
Keynote Address: Surprising Insights into BRCA1 Function
November 9, 2012
Speaker:
David M. Livingston, MD Dana-Farber/Harvard Cancer Center
Nanotechnology in Cancer Treatment: Hope, Hype, and Reality
November 9, 2012
Speaker:
P. Jack Hoopes, DVM, PhD
Linking Electronic Health Records and Registries to Study Predictors and Patterns of Breast Cancer Care
November 8, 2012
Speaker:
Amar K. Das, MD, PhD
Torrential Data from the Deep: Ion Torrent Deep Sequencing at Dartmouth
November 1, 2012
Speaker:
Joanna Hamilton, Ph.D., and Walter Taylor, PhD
A role for retrotransposons in regulating BRCA1 in sporadic breast cancers: Implications for diagnosis and prognosis
October 25, 2012
Speaker:
Giovanni Bosco, Ph.D.
Modulation of Lymphocyte Migration to Enhance Immune Therapy of Metastatic Melanoma
October 11, 2012
Speaker:
David W. Mullins, Ph.D. University of Virginia School of Medicine
Screening for Pancreatic Cancer in a High-Risk Population
October 4, 2012
Speaker:
Stuart R. Gordon, MD
Encouraging Novel Public Private Partnerships in Translational Research
September 20, 2012
Speaker:
John C. McKew, Ph.D., National Institutes of Health
Genetic Contributions to Smoking and Lung Cancer and Personalized Therapies
September 13, 2012
Speaker:
Christopher I. Amos, PhD
Development of Novel Bioimpedance-Based Devices for Assessing Prostate Cancer
June 14, 2012
Speaker:
Ryan J. Halter, Ph.D.
Dimensions of Survivorship: Addressing the 2015 Mandate, Are we Prepared? State of Survivorship / Current Projects at NCCC / Future Directions
June 7, 2012
Speaker:
Laura M. Urquhart, MS, APRN-BC, OCN / Claire M. Pace, MSN, FNP / Elizabeth B. McGrath, MS, APRN-BC, ACNP-BC, AOCNP, ACHPN, GNP-BC
Targeting the PI3K and CDK4 axes in endocrine-resistant breast cancer
May 31, 2012
Speaker:
Todd W. Miller, Ph.D., Assistant Professor of Pharmacology & Toxicology, Geisel School of Medicine at Dartmouth
GIST: Current Landscape in the Era of Personalized Medicine
May 24, 2012
Speaker:
Suzanne George, M.D., Clinical Director, Center for Sarcoma and Bone Oncology; Assistant Professor of Medicine, Harvard Medical School
The Future of Cancer Chemotherapy: A Brave New World
May 17, 2012
Speaker:
Alan Eastman Ph.D. Professor of Pharmacology & Toxicology
On a Mission to Prevent and Cure Cancer Where Do We Go From Here
April 26, 2012
Speaker:
Margaret Foti, Ph.D., M.D. (h.c.) Chief Executive Officer, AACR
Developing Effective Drug Combinations for the Prevention of Cancer
April 19, 2012
Speaker:
Karen T. Liby, Ph.D.
Leading Innovation in Health Care Delivery
April 12, 2012
Speaker:
Chris Trimble Adjunct Professor of Business Administration Tuck School of Business
Inflammation and Energy Balance in Cancer Risk and Prognosis
April 5, 2012
Speaker:
Cornelia Ulrich, Ph.D. Director, National Center for Tumor Diseases, Heidelberg, Germany
Estrogen-Receptor Biology Continuing Progress and Therapeutic Implications
March 22, 2012
Speaker:
Carmen Pisc, MD
Kinases in CLL: From B-Cell Receptor to the Bedside and Back
March 15, 2012
Speaker:
Alexy V. Danilov, MD, Norris Cotton Cancer Center
Fishin' for Inhibitors of NEMO ... and other tales from
March 8, 2012
Speaker:
Dale F. Mierke, PhD Professor of Chemistry, Dartmouth College
Pancreatic Cancer: Challenges and Hope
February 23, 2012
Speaker:
Wasif Saif, MD, Director, Cl. Sec. of GI Cancers; Medical Director, Pancreas Center; Columbia University College of Physicians and Surgeons; New York Presbyterian Hospital
Understanding the biology of melanoma to develop new strategies for therapy
February 2, 2012
Speaker:
Meenhard Herlyn, D.V.M, D.Sc. Professor and Program Leader, The Wistar Institute
Proteotoxic stress-targeted therapy: Improving on proteasome inhibition as anticancer therapy
January 25, 2012
Speaker:
Prof. Dr. Christoph Driessen, Dept. of Oncology/Hematology, Experimental Oncology, Clinical Trials Unit, Kantonsspital St. Gallen, St. Gallen, Switzerland
Moving Lung Cancer Research from the Bench to the Bedside
January 19, 2012
Speaker:
Ethan Dmitrovsky, MD, Chair, Pharmacology and Toxicology
Medicare Payment Reform & Cancer Care
December 15, 2011
Speaker:
Carrie Hoverman Colla, Assistant Professor, The Dartmouth Institute for Health Policy and Clinical Practice
Molecular and functioning imaging of cancer using magnetic resonance imaging (MRI) and spectroscopy (MRS)
December 8, 2011
Speaker:
Barjor Gimi, Ph.D., Assistant Professor, Radiology and of Medicine
From Translational to Transformational Medicine: Lessons from GIST and other Sarcomas to Accelerate Discovery and Development of Effective Anticancer Therapies
December 1, 2011
Speaker:
George Demetri, MD; Dana Farber
The Science Of Leading Yourself
November 10, 2011
Speaker:
Wiley W. Souba, MD, ScD, MBA Vice President for Health Affairs, Dartmouth College and Dean, Dartmouth Medical School
Leveraging the antibody Fc for more effective therapeutics
November 3, 2011
Speaker:
Margie Ackerman, PhD Thayer School of Engineering at Dartmouth College
Til Death Do Us Part: The Past, and Future, of Tobacco Control in the U.S
October 20, 2011
Speaker:
Kenneth E. Warner, PhD University of Michigan
